AD Harries, EJ Schouten, E Libamba - The Lancet, 2006 - thelancet.com
We are contemplating the future. For the past few months we have been working with our colleagues to prepare Malawi's antiretroviral treatment (ART) scale-up plan for 2006–10 …
B Schwartländer, I Grubb, J Perriëns - The Lancet, 2006 - thelancet.com
In March, 2006, the WHO took stock of the 3 by 5 initiative, which had been formally launched with UNAIDS 2 years earlier. 1 With 1· 3 million people on antiretroviral treatment …
Background Despite growing international pressure to provide HIV-1 treatment to less- developed countries, potential demographic and epidemiological impacts have yet to be …
As South Africa prepares for round two of a landmark legal struggle on April 18, which has raised hopes of cut-price drugs, notably for HIV/AIDS (see Lancet, March 10, p 775), the …
Essay www. thelancet. com Vol 364 September 25, 2004 1187 reduction will undoubtedly be at the core of a sustainable solution to HIV/AIDS. Therefore, investment in equitable …
S Satoh, E Boyer - The Lancet, 2019 - thelancet.com
South Africa is home to the largest HIV seropositive population in the world, with 7· 2 million individuals. 1 Since the country's first case of HIV in 1982, South Africa has come a long way …
L Ferradini, A Jeannin, L Pinoges, J Izopet… - The lancet, 2006 - thelancet.com
Background The recording of outcomes from large-scale, simplified HAART (highly active antiretroviral therapy) programmes in sub-Saharan Africa is critical. We aimed to assess the …
R Hecht, J Stover, L Bollinger, F Muhib, K Case… - The Lancet, 2010 - thelancet.com
As the global HIV/AIDS pandemic nears the end of its third decade, the challenges of efficient mobilisation of funds and management of resources are increasingly prominent …
Summary The" 3 by 5" goal to have 3 million people in low and middle income countries on antiretroviral therapy (ART) by the end of 2005 is ambitious. Estimates of the necessary …